Martin Wales

Martin Wales is a seasoned professional in the healthcare and pharmaceuticals sector, currently serving as a Senior Advisor at M&G Catalyst since April 2025 and as a Board Observer for both Nuclera and Osler Diagnostics. In addition, Martin holds a position as a Non Executive Director at CytoReason. Previously, Martin was a Senior Analyst and Head of Equity Research for M&G Investments, with a focus on Global Equity Research in Pharmaceuticals and Healthcare. Prior experience includes significant roles at UBS as a European Healthcare Analyst and at HSBC as a Healthcare Analyst. Martin began a career in research as a Senior Research Scientist at Celltech. Academic qualifications include a Ph.D. in Biochemistry from the University of Glasgow, a Postgraduate Diploma in Business Administration from the University of Warwick, and a BSc (Hons) in Biochemistry from the University of Bristol.